Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

198 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol.
Pavlides M, Mózes FE, Akhtar S, Wonders K, Cobbold J, Tunnicliffe EM, Allison M, Godfrey EM, Aithal GP, Francis S, Romero-Gomez M, Castell J, Fernandez-Lizaranzu I, Aller R, González RS, Agustin S, Pericàs JM, Boursier J, Aube C, Ratziu V, Wagner M, Petta S, Antonucci M, Bugianesi E, Faletti R, Miele L, Geier A, Schattenberg JM, Tilman E, Ekstedt M, Lundberg P, Berzigotti A, Huber AT, Papatheodoridis G, Yki-Järvinen H, Porthan K, Schneider MJ, Hockings P, Shumbayawonda E, Banerjee R, Pepin K, Kalutkiewicz M, Ehman RL, Trylesinksi A, Coxson HO; LITMUS Consortium Investigators; Martic M, Yunis C, Tuthill T, Bossuyt PM, Anstee QM, Neubauer S, Harrison S. Pavlides M, et al. Among authors: pericas jm. Contemp Clin Trials. 2023 Nov;134:107352. doi: 10.1016/j.cct.2023.107352. Epub 2023 Oct 4. Contemp Clin Trials. 2023. PMID: 37802221 Free article.
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. Among authors: pericas jm. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Review article: The need for more efficient and patient-oriented drug development pathways in NASH-setting the scene for platform trials.
Pericàs JM, Di Prospero NA, Anstee QM, Mesenbrinck P, Kjaer MS, Rivera-Esteban J, Koenig F, Sena E, Pais R, Manzano R, Genescà J, Tacke F, Ratziu V; EU-PEARL NASH Investigators. Pericàs JM, et al. Aliment Pharmacol Ther. 2023 May;57(9):948-961. doi: 10.1111/apt.17456. Epub 2023 Mar 14. Aliment Pharmacol Ther. 2023. PMID: 36918740 Review.
Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study.
Rivera-Esteban J, Jiménez-Masip A, Muñoz-Martínez S, Augustin S, Guerrero RA, Gabriel-Medina P, Ferrer-Costa R, Rodríguez-Frías F, Turu E, Marco A, Pericàs JM, On Behalf Of The Prisonafld Study Group Collaborators. Rivera-Esteban J, et al. Among authors: pericas jm. J Clin Med. 2023 Nov 24;12(23):7276. doi: 10.3390/jcm12237276. J Clin Med. 2023. PMID: 38068330 Free PMC article.
NAFLD as the metabolic hallmark of obesity.
Rojano A, Sena E, Manzano-Nuñez R, Pericàs JM, Ciudin A. Rojano A, et al. Among authors: pericas jm. Intern Emerg Med. 2023 Jan;18(1):31-41. doi: 10.1007/s11739-022-03139-x. Epub 2022 Nov 10. Intern Emerg Med. 2023. PMID: 36357606 Review.
Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes.
Rivera-Esteban J, Pons M, Planas A, Manzano-Nuñez R, Hernández C, Simó-Servat O, Bañeras J, Soler MJ, Seron D, Boixadera A, Augustin S, Simó R, Ferreira-González I, Genescà J, Pericàs JM; PRECISED consortium. Rivera-Esteban J, et al. Among authors: pericas jm. Gastroenterol Hepatol. 2023 Nov;46(9):682-691. doi: 10.1016/j.gastrohep.2022.11.001. Epub 2022 Nov 23. Gastroenterol Hepatol. 2023. PMID: 36435379 English, Spanish.
Correction: LiverScreen project: study protocol for screening for liver fibrosis in the general population in European countries.
Graupera I, Thiele M, Ma AT, Serra-Burriel M, Pich J, Fabrellas N, Caballeria L, de Knegt RJ, Grgurevic I, Reichert M, Roulot D, Schattenberg JM, Pericas JM, Angeli P, Tsochatzis EA, Guha IN, Garcia-Retortillo M, Morillas RM, Hernández R, Hoyo J, Fuentes M, Madir A, Juanola A, Soria A, Juan M, Carol M, Diaz A, Detlefsen S, Toran P, Pera G, Fournier C, Llorca A, Newsome PN, Manns M, de Koning HJ, Serra-Burriel F, Cucchietti F, Arslanow A, Korenjak M, van Kleef L, Falcó JL, Kamath PS, Karlsen TH, Castera L, Lammert F, Krag A, Ginès P; LiverScreen Consortium investigators. Graupera I, et al. Among authors: pericas jm. BMC Public Health. 2023 May 22;23(1):923. doi: 10.1186/s12889-023-15867-6. BMC Public Health. 2023. PMID: 37217864 Free PMC article. No abstract available.
198 results